Big Pharma Needs Luck

Deepak Singh at bbgm ponders an article he read in the Financial Times that pairs drug discovery and serendipity. There is a role for serendipity in drug discovery, but the declining productivity of the pharma industry is not necessarily due to lazy scientists who can't innovate, he says. Systems biology is tough -- and managing and understanding all the data from these experiments is no easy task.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.